 |
|
|
| |
CM-101 a novel CCL24 blocking monoclonal antibody
ameliorates hepatic injury in NASH induced mouse model
|
| |
| |
Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
Ben-Ari Z1,5, Segal-Salto M2, Katav A2, Hashmueli S2, George J2,3,5, Haberman D3, Maor Y4, Mor A2
1Liver Diseases Center, Sheba Medical Center, Ramat Gan, 2ChemomAb Ltd, Tel Aviv, 3Heart Institute, and 4Liver diseases service, Kaplan Medical Center, Rehovot, 5Sackler School of Medicine, Tel Aviv University, Israel
|
| |
|
|
|
|
|
